Wells Fargo
BMY.RT

Wells Fargo’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Wells Fargo’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-300,677
Closed -$207K – 7781
2020
Q4 		$207K Sell
300,677
-172,864
-37% -$368K ﹤0.01% 5073
2020
Q3 		$1.06M Sell
473,541
-559,882
-54% -$1.6M ﹤0.01% 3810
2020
Q2 		$3.7M Sell
1,033,423
-371,248
-26% -$1.34M ﹤0.01% 2760
2020
Q1 		$5.34M Sell
1,404,671
-2,366,219
-63% -$7.79M ﹤0.01% 2184
2019
Q4 		$11.3M Buy
+3,770,890
New +$9.81M ﹤0.01% 1882

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Wells Fargo's BMY.RT Position: Q1 2021 in Review

Wells Fargo sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 300,677 shares — an estimated $207K sold.

Wells Fargo first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $11.3M in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Wells Fargo reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Wells Fargo sold 300,677 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $207K.
  • Wells Fargo first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Wells Fargo's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $11.3M in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Wells Fargo's 13F filing for Q1 2021, filed 13 May 2021.